🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesSURPASS-CVOT: tirzepatide cardiovascular outcomes trial design — looking for input Page 4

SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design — looking for input

Admin Sat, Jul 12, 2025 at 7:09 AM 40 replies 1,896 viewsPage 4 of 8
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Jul 12, 2025 at 12:49 PM#16

Congrats KarenAZ_mom!! You should be so proud of yourself. 🎉

16 20emma_london, tammy_FL, Dr.LipidDallas and 13 others
Reply Quote Save Share Report
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Jul 12, 2025 at 1:06 PM#17

Admin's experience with SURPASS-CVOT tirzepatide resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I am on a different medication. But the overall trajectory has been remarkably similar. Down 43 lbs in 8 months.

One thing I would add that Admin did not mention: my sleep quality improved dramatically.

Last edited: Jul 12, 2025 at 3:06 PM
2 9james_edin, FranDenver
Reply Quote Save Share Report
kim_atl_prep
Member
312
1,345
Aug 2024
Atlanta, GA
Jul 12, 2025 at 1:23 PM#18

Bookmarked 📌 The SURPASS-CVOT info in this thread is essential. Coming back to this for sure.

46 0RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 43 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Jul 12, 2025 at 1:40 PM#19

Clinical perspective on SURPASS-CVOT tirzepatide cardiovascular:

I have managed over 200 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that proper titration prevents most adverse events.

For this specific question, I would recommend: reviewing the relevant clinical guidelines.

39 16tom_AK, josh_phd_bmore, roxy_nash and 36 others
Reply Quote Save Share Report
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
Jul 12, 2025 at 1:57 PM#20

Subscribing to this thread. SURPASS-CVOT tirzepatide is exactly what I've been researching. 🙏

41 17maria_elpaso, anders_CPH, Dr.NutriCornell and 38 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register